{
  "pmid": "39786840",
  "title": "The effects of deucravacitinib on three cases of systemic sclerosis associated with psoriasis.",
  "abstract": "",
  "pub_date": "2025-06-01",
  "publication_types": [
    "Journal Article"
  ],
  "affiliations": [
    "Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.",
    "Department of Clinical Cannabinoid Research, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.",
    "Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.",
    "Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.",
    "Department of Clinical Cannabinoid Research, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.",
    "Systemic Sclerosis Center, The University of Tokyo Hospital, Tokyo, Japan.",
    "Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.",
    "Systemic Sclerosis Center, The University of Tokyo Hospital, Tokyo, Japan."
  ],
  "url": "https://pubmed.ncbi.nlm.nih.gov/39786840/",
  "snapshot_id": "2026-02-12T15-10-27Z",
  "ingested_at": "2026-02-12T15:10:32.228780+00:00"
}